Hearing company Decibel Therapeutics nabs $52 mln Series A
Cambridge, Massachusetts-based hearing company Decibel Therapeutics has launched with $52 million in Series A funding. Third Rock Ventures LLC led the round with participation from SR One. In addition to the funding, Kevin Starr, chairman and interim CEO of Decibel Therapeutics, Craig Muir, partner and chief technology officer at Third Rock and Dr. Jens Eckstein, president of SR One, have been named to Decibel Therapeutics' board of directors.
15 October 2015•5 mins read
